Table 1 Demographic and clinical characteristics of women with and without post-cancer fatigue (PCF) after adjuvant treatment for breast cancer
Patient groups; mean (SD) or percentage | |||
|---|---|---|---|
| Â | PCF (n = 98) | Non-fatigued (n = 77) | P |
Age (years) | 56 (11.5) | 55 (11.5) | ns |
Months since treatment completion | 10 7 (6.1) | 10.5 (5.6) | ns |
Surgical treatment (% of group) | Â | Â | Â |
   Mastectomy | 45.5 | 41.5 | ns |
   Lumpectomy | 54.5 | 58.5 | ns |
Adjuvant treatment (% of group) | Â | Â | Â |
   Chemotherapy | 14.3 | 12.6 | ns |
   Radiotherapy | 45.5 | 53.7 | ns |
   Combined chemotherapy and radiotherapy | 40.3 | 33.7 | ns |
Menopausal status at follow-up (% of group) | Â | Â | Â |
   Pre-/peri-menopausal | 34 | 39 | ns |
   Postmenopausal | 66 | 61 | ns |